Results 161 to 170 of about 8,134,851 (321)
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source
Key Insights From the International ICU Diary Conference 2025. [PDF]
Nurs Crit CareNydahl P +17 more
europepmc +1 more source
4th National Conference on "Recent Advancements in Civil Engineering (RACE-23)"
, 2023 Kongunadu College of Engineering and Technology (KNCET)
openalex +1 more source
Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig +9 more
wiley +1 more source
Arthritis Care &Research, EarlyView.Objective We evaluated the ability of the Renal Activity Index for Lupus (RAIL) to discriminate active lupus nephritis (LN) in adult patients with active systemic lupus erythematosus (SLE) and differentiate LN treatment response. Methods Urine samples from adults with biopsy‐proven active class III and IV LN from TULIP‐LN (active LN group ...
Hermine I. Brunner +12 more
wiley +1 more source
CHLA/ABSC Mosaic Conference: Contributed Papers
Journal of the Canadian Health Libraries Association, 2016 CHLA Conference
doaj +1 more source
Catalyzing collaboration through intentional design: the Teaming for Biomedical Digital Twin (Teaming4BDT) conference. [PDF]
Front PsycholBennett LM, Xiao Z.
europepmc +1 more source
Arthritis Care &Research, EarlyView.Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti +19 more
wiley +1 more source
Presentation abstracts / Resumes des exposes
Journal of the Canadian Health Libraries Association, 2014 CHLA Conference
doaj +1 more source